To: Mason Barge who wrote (663 ) 9/14/1999 3:41:00 PM From: Ram Seetharaman Read Replies (1) | Respond to of 717
After 4 months, there is some news today! I am not sure if MS will go to $ 2+ this year! LIVINGSTON, N.J., Sep 14, 1999 (BUSINESS WIRE) -- Milestone Scientific Inc. (AMEX:MS) today announced that the Certification Office for Medical Devices of the European Economic Community had approved the use of The Wand(TM), Milestone¡¯s computer controlled anesthetic injection delivery system, in medical applications. The Wand is currently being marketed for dental use in the European Economic Community. Leonard Osser, Chairman and Chief Executive Officer of Milestone, said, "The acceptance of The Wand for use in medical applications in the European Economic Community represents a tremendous breakthrough for our painless injection technology. We believe that this acceptance will pave the way for similar acceptance in the United States and other parts of the world. Clinical evaluations are currently being conducted to show the benefits from use of The Wand in podiatry, dermatological surgery, and gynecology. A clinical trial in the United States has previously been conducted in colorectal surgery. Other areas for use of The Wand technology may also be investigated. Milestone continues to work on the development of new technologies geared to meet the particular needs of the medical and dental professions." Milestone Scientific Inc. is the developer, manufacturer and marketer of The Wand(TM), a computer activated, precision metered, local anesthetic injection system that enables virtually painless injections to be administered consistently. This releases contains certain forward-looking statements which involve known and unknown risks, uncertainties or other factors not under the Company¡¯s control, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations implied by these forward-looking statements. These factors include, but are not limited to, those detailed in the Company¡¯s periodic filings with the Securities and Exchange Commission.